Carduso Capital Groningen invests in DEAM Holding BV.

DEAM is a young company co-based in Groningen that develops precision medical devices, specialising in steerable, minimally invasive instruments. The DEAM instruments are steerable in all directions, making it possible for surgeons to get an optimal operating position, also in areas that are not easy to reach or access. The DEAM steerable instruments offer great benefits in combination with the latest 3D-imaging technologies used during surgery.

Read more ...

Carduso Capital invests in BioBTX

Press release

BioBTX is a company based in Groningen-NL that produces chemicals (Aromatics) from Biomass. This technique allows the manufacturing of ‘green' plastics. BTX stands for benzene, toluene and xylene. These chemicals are normally extracted from natural crude oil and form the building blocks for plastics. BioBTX developed a way in which the oil can be replaced by biomass.

Read more ...

Carduso Capital Groningen invests in BiOrion Technologies BV

Press release

Carduso Capital Groningen invests in BiOrion Technologies BV, a spin-off company of the University of Groningen.

BiOrion Groningen is a biopharmaceutical company that develops products for the diagnosis and treatment of fibrosis, the process of formation of excess fibrous connective tissue in organs such as liver, kidney, heart or lungs by which they may turn-out completely. BiOrion has raised additional capital from the Carduso Capital investment Fund for the clinical validation of its proprietary drug-targeting technology.

Read more ...

Carduso Capital invests in PureIMS

Carduso Capital invests in PureIMS, a University of Groningen Spin-off developing the Twincer® dry powder inhalation technology

Read more ...

Carduso recognize the potential of Twincer

The Twincer®, a CE registered breath activated dry powder inhaler for single use with its patented classifier technology.

Page 1 of 2